Progressive
Care Inc. Announces 40% Year-Over-Year Increase in
Prescriptions Filled and Continued Strong Revenues in
September
2018
Miami,
FL -- October
16, 2018 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD),
a personalized
healthcare
services and technology company, today announced further growth
year-over-year in both revenue and number of prescriptions filled
for September 2018.
In
September, the company reported a total of $1.6 million in net
revenue, a 7% increase from the same month last year, and
a 40%
increase in prescriptions filled during
the same month last year, totaling more than 24,300 filled
prescriptions.
Progressive
Care's wholly-owned
subsidiary
PharmCo, LLC saw a record month for
prescriptions filled in September, reporting a 23% increase in
prescriptions filled over the same month last year, totaling more
than 21,350 prescriptions. The company's newest PharmCo facility,
Touchpoint Rx (dba PharmCo Rx 1002), reported just over 3,000
prescriptions filled during the month of August and nearly $100,000
in revenue. The growth is a result of Progressive
Care's continued development of the
company
following the completed
acquisition of
the pharmacy in early July of this year.
"As we close out another strong
quarter, we are proud to report another equally strong month of
sales and prescription numbers. These results illustrate our
ongoing dedication and commitment to providing patients with a full
range of personalized pharmacy services," said S. Parikh Mars, Chief
Executive Officer of Progressive Care Inc. "We are pleased with the growth
we are seeing from our PharmCo West Palm Beach facility (formerly
referenced as Touchpoint Rx). We are excited about all of the
progress and opportunities we have now because of the recognition
of our unique approach and breadth of pharmacy
services."
Other recent company
announcements include the
launch of
an updated
website for
Progressive Care's wholly owned subsidiary,
PharmCo LLC, dedicated to providing patients with additional
knowledge on its growing platform of offered products and suite of
services. The company also
announced a
record number of prescriptions filled in August 2018, with a 44%
increase in prescriptions filled during the same month last
year.
For[1] more
information about Progressive Care, please visit the
company's
website.
Connect and stay in touch with
us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care
Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida
health services organization and provider of prescription
pharmaceuticals, compounded medications, provider of tele-pharmacy
services, the sale of anti-retroviral medications, medication
therapy management (MTM), the supply of prescription medications to
long term care facilities, and health practice risk
management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the
Company's
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words
"anticipate,"
"believe,"
"estimate,"
"upcoming,"
"plan,"
"target,"
"intend"
and
"expect"
and similar expressions, as they relate to Progressive Care Inc.,
its subsidiaries, or its management, are intended to identify such
forward-looking statements. These forward-looking statements are
based on information currently available to the Company and are
subject to a number of risks, uncertainties, and other factors that
could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Investor Relations Contact:
Armen
Karapetyan, Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations Contact:
Tory
Patterson, CMW Media
Tory@cmwmedia.com
www.cmwmedia.com
Web and Application Development Contact:
Marcello Jaspan,
Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com